Table 12.1(continued)Location# patients in studyRoute of exposureClinical presentationAllergens (molecularweights)ReferenceMilwaukee,WI (USA)28Smoking moldcontaminated marijuanaMostly asymptomatic,some withbronchospasmN/A(Kagen et al.1982)Valladolid,Spain140 total with 53.2%patients positive forCannabisskin prick testand 34.3% patientspositive for specific IgEGeneral allergic patientsand drug-dependentusersAsthma, urticaria,rhinitis andanaphylaxis in somecasesN/A(Armentia et al. 2011)Benidorm,Tres CantosandOrihuela,Spain32 patients atopic totomato including 10 withallergic reactions toCannabisexposureTomato-sensitizedpatients with contact orinhalation exposure toCannabisUrticaria,rhinoconjunctivitis,itching and in somecases asthma-likesymptoms andpalpebral angioedema9 –10, 14, 30- 35, 45
(de Larramendiet al.2007,^2008)Multi-centerstudy, Spain44 patients tested positiveforC. sativaSmoking and handlingofC. sativaBroad respiratory andcutaneous symptomswith sporadic cases ofanaphylaxis10 and 14 kDa(LTP) and 38 kDa(thaumatin-like protein)(Larramendi et al. 2013)Toronto,Canada17Smoking and contactexposure. One patientconsumed marijuana teaRhinitis, conjunctivitis,sinusitis, wheezing,contact urticaria withperiorbital angioedemaand abdominalcramping in few casesMajor immunoreactivebands at 50 and 23identified as RuBisCOand OEP2 respectively.Other minor allergensranged from 10 to100 kDa.(Nayak et al.2013;Tessmer et al. 2012)Bakersfield,CA (USA)1Intravenous personalexposureFacial edema, pruritus,wheezing and dyspneaN/A(Perez2000)
(continued)12 Allergenicity toCannabis sativaL.... 267